Cargando…
Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells
The urokinase plasminogen activator receptor (uPAR) has been proposed as a potential prognostic factor for various malignancies. The aim of this study is to assess the prognostic value of uPAR expression in neoplastic and stromal cells of patients with pancreatic adenocarcinoma. Urokinase plasminoge...
Autores principales: | de Geus, Susanna WL, Baart, Victor M, Boonstra, Martin C, Kuppen, Peter JK, Prevoo, Hendrica AJM, Mazar, Andrew P, Bonsing, Bert A, Morreau, Hans, van de Velde, Cornelis JH, Vahrmeijer, Alexander L, Sier, Cornelis FM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484551/ https://www.ncbi.nlm.nih.gov/pubmed/28690396 http://dx.doi.org/10.1177/1177271917715443 |
Ejemplares similares
-
Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
por: Boonstra, Martin C, et al.
Publicado: (2014) -
Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins
por: Boonstra, Martin C., et al.
Publicado: (2016) -
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
por: Baart, V. M., et al.
Publicado: (2020) -
Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
por: Tummers, Willemieke S., et al.
Publicado: (2017) -
Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy
por: Boogerd, Leonora SF, et al.
Publicado: (2018)